Search alternatives:
mean decrease » a decrease (Expand Search)
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
mean decrease » a decrease (Expand Search)
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
681
-
682
-
683
-
684
-
685
FABP5 overexpression decreases inflammation and increases innate immunity in primary NHBE cells.
Published 2013“…<p><b>A.</b> CS exposure decreases <i>P. aeruginosa</i> colony forming units (CFU) on primary NHBE cells overexpressing FABP5. …”
-
686
-
687
Image 5_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
Published 2025“…Moreover, 5 of the decreased autoantibodies can also be applied for supervising bone metastasis in lung adenocarcinoma. …”
-
688
-
689
-
690
-
691
-
692
MiR-129-5p levels were decreased in mouse depression models.
Published 2025“…</b> Relative expression of miR-129-5p in the control and CRS groups. <b>M.</b> Relative expression of miR-129-5p in the CTX, HIP, and HB of control and CRS mice. …”
-
693
-
694
Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells.
Published 2014“…1<p>Phosphopeptides with MAPK site in either 1 or 2(*) experiments, p<0.05, 1.5× decreased after 1NM-PP1 treatment.</p>2<p>Showed reduced expression in Δ<i>pp-1</i> germlings (19).…”
-
695
-
696
Effects of adenosine receptor-specific antagonists on responses to hypoxia at E9.5 and E12.5.
Published 2013“…<p>A and B: Specimens were treated with DPCPX, an A1AR-specific antagonist at 10 nM (A: E9.5, n = 15; B: E12.5, n = 23), SCH-58261, an A2aAR-specific antagonist at 100 nM (A: E9.5, n = 15; B: E12.5, n = 19), or vehicle (A: E9.5, n = 27; B: E12.5, n = 42) at 15 min (arrows), and exposed to hypoxia (gray boxes). …”
-
697
TRIM5 restriction of HIV-1 has decreased during evolution leading to humans.
Published 2013“…<p>The shading of the rectangle represents the degree that TRIM5 will limit infection of HIV-1 (darker color means TRIM5 decreases HIV-1 infection more) and the X-axis indicates time in millions of years from the present. …”
-
698
-
699
-
700